Btk inhibitor 1
#
-
Catalog numberHY-13036
-
Price:
-
Size50mg
-
-
Alternative_NamesNA
-
CAS1412418-47-3
-
MWt386.45
-
FormulaC22H22N6O
-
Solubility10 mM in DMSO
-
Clinical_InformationNo Development Reported
-
PathwayProtein Tyrosine Kinase/RTK
-
TargetBtk
-
DescriptionTissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.
-
Gene target
-
Short nameBtk inhibitor 1
-
Alternative nameBruton agammaglobulinemia tyrosine kinase suppressor 1
-
Alternative to gene targetBruton agammaglobulinemia tyrosine kinase, AGMX1 and AT and ATK and BPK and IMD1 and PSCTK1 and XLA, BTK and IDBG-79651 and ENSG00000010671 and 695, phosphatidylinositol-3, nuclei, Btk and IDBG-171427 and ENSMUSG00000031264 and 12229, BTK and IDBG-633447 and ENSBTAG00000019250 and 533459
-